跳至主要内容
临床试验/ISRCTN57612064
ISRCTN57612064已完成不适用

Efficacy trial of human papillomavirus (HPV) versus Pap testing for screening cervical cancer precursors: a randomised controlled trial

McGill University (Canada) - Research Grants Office0 个研究点目标入组 10,154 人开始时间: 2005年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10,154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 05/01/2010:
  • 1. Women aged 30 to 69 years
  • 2. Sought screening tests for cervical cancer in any of 30 family practice or gynaecology clinics in Montreal and St. John's, Canada
  • Initial inclusion criteria at time of registration:
  • 1. Women aged between 30 and 69 years
  • 2. Currently attending a colposcopy clinic for evaluation, treatment or follow up of a cervical lesion

排除标准

  • Current exclusion criteria as of 05/01/2010:
  • 1. Currently being followed up for a cervical lesion
  • 2. Lacked a cervix
  • 3. Pregnant
  • 4. Had a history of cervical cancer
  • 5. Had undergone Pap testing in the previous year
  • 6. Unable to provide consent were excluded (note that this is related also to the ability to understand French or English)
  • Initial exclusion criteria at time of registration:
  • 1. Without a cervix
  • 2. Pregnant
  • 3. History of cervical cancer
  • 4. Known human immunodeficiency virus (HIV) infection
  • 5. Mentally incompetent
  • 6. Unable to understand French or English
  • 7. Refuse to provide an informed consent

研究者

发起方
McGill University (Canada) - Research Grants Office

相似试验

The Canadian Cervical Cancer Screening Trial of... | 临床试验